Bausch Health Companies Investor Conference Presentation Deck
21
TTM¹ Adjusted EBITDA² ($M)
Net loss attributable to Bausch Health Companies Inc.
Interest expense, net
Benefit from income taxes
Depreciation and amortization
EBITDA
Adjustments:
Asset impairments, including loss on assets held for sale
Goodwill impairments
Restructuring and integration costs
Acquisition-related costs and adjustments (excluding
amortization of intangible assets)
Loss on extinguishment of debt
Share-based compensation
Separation costs, separation-related costs, IPO costs and
IPO-related costs
Other adjustments:
Litigation and other matters
IT infrastructure investment
Legal and other professional fees
Net gain on sale of assets
Acquired in-process research and development costs
Other
2
Adjusted EBITDA (non-GAAP) ²
BAUSCH- Health
Sep-21
$ (1,170)
1,454
$
(278)
1,617
1,623
1. Trailing twelve months.
2. See Slide 2 and this Appendix for further non-GAAP information..
310
469
8
30
70
119
138
615
22
56
(2)
15
1
3,474
Jun-21
Mar-21
Dec-20
$ (1,287) $ (1,018) $ (560)
1,477
1,498
1,521
$
(298)
1,671
1,563
294
469
6
24
58
113
102
831
21
51
(23)
27
1
3,537
$
(333)
1,747
1,894
248
469
10
26
40
109
61
399
19
47
(23)
33
1
3,333
$
(375)
1,825
2,411
114
11
48
59
105
32
422
21
39
(1)
32
1
3,294
Sep-20
$ (1,923)
1,532
$
(86)
1,889
1,412
43
15
36
53
106
LO
5
1,516
25
41
(22)
52
(1)
3,281View entire presentation